148 related articles for article (PubMed ID: 36037113)
1. Prognostic Role of Oncogenic and Tumor-Suppressing miRNA Types in Egyptian Uterine Cancer Patients.
Salim EI; Beltagy DM; Elmashad NM; Abodonia MA
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2607-2615. PubMed ID: 36037113
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
3. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
[TBL] [Abstract][Full Text] [Related]
4. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract][Full Text] [Related]
5. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
[TBL] [Abstract][Full Text] [Related]
6. [The role of miRNA in endometrial cancer in the context of miRNA 205].
Wilczyński M; Danielska J; Dzieniecka M; Malinowski A
Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318
[TBL] [Abstract][Full Text] [Related]
7. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro.
Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S
Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686
[TBL] [Abstract][Full Text] [Related]
9. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
11. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.
Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in endometrial cancer.
Banno K; Yanokura M; Kisu I; Yamagami W; Susumu N; Aoki D
Int J Clin Oncol; 2013 Apr; 18(2):186-92. PubMed ID: 23380959
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
15. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
19. The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.
Yamamoto N; Nishikawa R; Chiyomaru T; Goto Y; Fukumoto I; Usui H; Mitsuhashi A; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2015 Jul; 47(1):325-34. PubMed ID: 25955017
[TBL] [Abstract][Full Text] [Related]
20. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]